Moreover, CANX KO cells expressing these variants appear to exhibit less sensitivity to treatment with the combination of VX-661 and VX-445 (Fig. 1 B & C)- two correctors contained within the CF therapeutic Trikafta. The gene discussed is CANX; the disease is cystic fibrosis.